23andMe Worries
When 23andMe went public in 2021, it was a big deal. The popularity of its genetic tests carried the company to a valuation of US$6 billion. But in recent times, some dramatic changes have occured with its leadership and finances, and now 23andMe is worth very little. This leads to some worries about the future … Read more